A Guide to
www.ShireSupport.com
Updated: Spring 2012
Shire Pharmaceuticals-SP
Our purpose
We enable people with life-altering conditions to lead better lives.
www.ShireSupport.com
• The following slides provide an orientation on
•
•
•
•
•
•
•
Shire Pharmaceuticals-SP
Registration eligibility and submission
Therapeutic areas
Funding types
Definitions of funding types
Funding availability
Contact information
To be as brave as the people we help.
2
Registration and Submission Process
• Step One
• Become a registered user of www.ShireSupport.com
• When registering please have the following materials available
• Legal name of the organization as registered with the IRS
• A signed PDF copy of the organization’s W9 form
• Note: Electronic signatures are NOT acceptable
• If applicable, a PDF copy of the organization’s non-profit
determination letter from the IRS
• Step Two
• Select the request type
• Medical education grants
• Healthcare related Charitable Contributions and/or Sponsorship
requests
• Step Three
• Submit the request with attachments as applicable
To be as brave as the people we help.
3
Registration Eligibility
• Eligible
• Medical Schools
• Hospitals/Medical Centers
• Medical Associations/Medical
Societies
• Patient Advocacy
Organizations
• Medical Education Companies
• Not for Profit organizations
•
• Ineligible
• Individuals
• Private or group medical
practice(s)
• An organization that has been
debarred or is on the OIG
exclusion list
501(c)(3)(4)(6)
Notice to all requestors located in Massachusetts: due to the Massachusetts Pharmaceutical and Device Manufacturer Conduct Law, Shire is
unable to fund requests for the financial support for the costs of travel, lodging, or other personal expenses of non-faculty health care
practitioners attending any CME event, third-party scientific or educational conference, or professional meetings, either directly to the
individuals participating in the event or indirectly to the event’s sponsor. While Shire has information on the charitable section of this website
relating to Fellows and Residents travel grants, any organizations located in Massachusetts are not eligible due to this law.
To be as brave as the people we help.
4
Therapeutic Areas of Interest
• ADHD
• Adult
• ADHD is a chronic neurologically based disease. Therefore Shire’s
educational goal is to fund education that provides specialists with the
information and tools needed to improve the screening, diagnosis,
treatment, and management of adult patients with ADHD.
• Adolescents
• ADHD is a chronic neurologically based disease. Therefore Shire’s
educational goal is to fund education that provides specialists with the
information and tools needed to improve the screening, diagnosis,
treatment, and management of adolescent patients with ADHD.
• Pediatric
• ADHD is a chronic neurologically based disease. Therefore Shire’s
educational goal is to improve the screening, diagnosis, treatment, and
management of pediatric patients with ADHD.
To be as brave as the people we help.
5
Therapeutic Areas of Interest
• Gastroenterology
• Mild to Moderate Ulcerative Colitis
• Mild to moderate ulcerative colitis is a disease characterized by inflammation
and ulceration of the lining of the colon and rectum. Shire’s educational goal
is to fund education that provides specialists with the information and tools
needed to improve the screening, diagnosis, treatment, and management of
patients with mild to moderate ulcerative colitis.
• Motility/Chronic Constipation
• Chronic constipation is characterized by infrequent and difficult passage of
stools over a prolonged period and a range of bothersome symptoms.
Shire’s educational goal is to fund education that provides specialists with
the information and tools needed to improve the screening, diagnosis,
treatment, and management of female patients with chronic constipation.
• Renal
• Hyperphosphatemia
• Hyperphosphatemia is an abnormal concentration of phosphates in the
blood. Shire’s educational goal is to fund education that provides specialists
with the information and tools needed to improve the screening, diagnosis,
treatment, and management of patients with hyperphosphatemia.
To be as brave as the people we help.
6
Definitions of Funding Types
Funding Request Type
Definition
Therapeutic Areas
Independent Medical Education
Grant
Consists of educational activities, which
serve to maintain, develop, or increase the
knowledge, skills, and professional
performance, and relationships that a
physician uses to provide services for
patients, the public, or the profession.
Shire Pharmaceuticals-SP
Examples include:
General meeting support for healthcare
practitioner conference
Annual conference at medical school or
association meeting
Session at annual meeting of local medical
society
Educational grants may be payable to
organizations including hospitals, medical
societies, medical schools, 501(c)(3)(4)(6)
organizations, medical education companies,
etc.
Funds are to educate broad audiences;
cannot be used to fund education for sole
individual.
• Gastroenterology – Mild to
Moderate Ulcerative Colitis
• Gastroenterology – Motility/Chronic
Constipation
• Hyperphosphatemia (Renal)
• Pediatric Attention Deficit Hyperactivity
Disorder
• Adolescent and Adult Attention Deficit
Hyperactivity Disorder
www.ShireSupport.com
Requesting organization has full control over
selection of faculty, content, educational
method, materials, venue etc.
Shire has no role in the development or
implementation of the activity.
To be as brave as the people we help.
7
Definitions of Funding Types
Funding Request Type
Definition
Therapeutic Areas
Charitable Contributions
Donations to support the general activities of
a registered tax-exempt organization under
sections 501(c)(3)(4)(6) of the Internal
Revenue Code, which are engaged in
healthcare-related charitable purposes
Shire Pharmaceuticals-SP
Examples include:
Fundraising events
General support of patient advocacy
organizations
All charitable giving must serve a clearly
defined legitimate charitable purpose, and
Shire may only receive an incidental benefit
from any such contributions
Charitable contributions may be payable to
organizations including hospitals, medical
societies, medical schools, 501(c)(3)(4)(6)
organizations, etc.
• Gastroenterology specific to mild to
moderate ulcerative colitis
•Gastroenterology – Motility/Chronic
Constipation
•Hyperphosphatemia (Renal)
• Pediatric attention deficit hyperactivity
disorder
• Adult attention deficit hyperactivity disorder
www.ShireSupport.com
Use of charitable contribution funds is
unrestricted, which means Shire does not
control the recipient’s use of the funds; use is
at the sole discretion of the recipient
Notice to all requestors located in Massachusetts: due to the Massachusetts Pharmaceutical and Device Manufacturer Conduct Law, Shire is unable to fund
requests for the financial support for the costs of travel, lodging, or other personal expenses of non-faculty health care practitioners attending any CME
event, third-party scientific or educational conference, or professional meetings, either directly to the individuals participating in the event or indirectly to the
event’s sponsor. While Shire has information on the charitable section of this website relating to Fellows and Residents travel grants, any organizations
located in Massachusetts are not eligible due to this law.
To be as brave as the people we help.
8
Definitions of Funding Types
Funding Request Type
Definition
Therapeutic Areas
Sponsorship Requests
Support for healthcare-related events or
activities where Shire may receive a material
commercial benefit in exchange for its
contribution
Shire Pharmaceuticals-SP
Examples include:
Payments to become a tier (e.g., gold,
platinum, etc.) sponsor at a medical society’s
or patient advocacy group’s annual meeting
Payment for exhibit space at a medical
conference or seminar
Patient Education
Sponsorships may be payable to
organizations including hospitals, medical
societies, medical schools, 501(c)(3)(4)(6)
organizations, etc.
Shire does not fund sponsorships payable to
individual healthcare providers or medical
practices.
• Gastroenterology specific to mild to
moderate ulcerative colitis
•Gastroenterology – Motility/Chronic
Constipation
•Hyperphosphatemia (Renal)
• Pediatric attention deficit hyperactivity
disorder
• Adult attention deficit hyperactivity disorder
www.ShireSupport.com
To be as brave as the people we help.
9
Shire Pharmaceuticals-SP – 2012 Funding Availability
Therapeutic Area
Educational Grants
Healthcare Related Charitable
Contributions and/or
Sponsorship Requests
Limited
Available
Gastroenterology – Mild to
Moderate Ulcerative Colitis
Available
Available
Gastroenterology –
Motility/Chronic Constipation
Available
Available
Hyperphosphatemia (Renal)
Limited
Limited
Pediatric Attention Deficit
Hyperactivity Disorder
Limited
Available
Adolescent and Adult Attention
Deficit Hyperactivity Disorder
To be as brave as the people we help.
10
Financial Reconciliation of Educational Grants
•
•
•
Educational grants must be reconciled within 90 days of the activity
date
Reconciliations are to be completed online at www.ShireSupport.com
What’s needed
• Complete the online reconciliation form with
• Attendance information
• Comparative budget to actual reconciliation (Program expenses for the
entire initiative; not just what Shire provided)
• Total Funding received from all sources = registration income, educational
grants, and funding provided by the hosting organization
• The evaluation summary
• Documentation of the commercial support acknowledgement statement, i.e.
“This activity was supported by an independent medical educational grant
from Shire.”
• Refunds are only due if the amount is greater than $250
•
Failure to reconcile educational grants may prevent future funding to
your organization.
To be as brave as the people we help.
11
Financial Reconciliation of Sponsorships
• All sponsorships must be reconciled within 90 days of
the activity date
• Reconciliations are to be completed online at
www.ShireSupport.com
• What’s needed
• Comparative budget to actual reconciliation
• Program expenses for the entire initiative must be included (not just
funding provided by Shire)
• Documentation of the commercial support acknowledgement
statement
• Note that failure to reconcile this request may prevent
future Charitable and/or Sponsorship funding to your
organization.
To be as brave as the people we help.
12
Some Reminders…
•
•
Funding requests must be aligned to a Shire Pharmaceuticals-SP therapeutic area of
interest to be considered
Funding requests must be submitted online to www.ShireSupport.com by the
requesting organization without assistance from Shire employees
•
•
•
Funding requests must be in compliance with all applicable guidelines
Timelines
•
•
•
•
•
•
•
Faxed, mailed, or e-mailed requests will not be reviewed
All requests – educational, charitable contributions, or sponsorships – must be submitted 60
days in advance
Decisions are communicated by e-mail within 30-60 days of the request date
Requests will not be reviewed or approved after the activity has begun or taken place
Submission, or past approvals, does not guarantee support
Declined requests cannot be resubmitted
Educational grant requests should not include sponsorship requests and vice versa
Questions?
• Shire Pharmaceuticals-SP: ShireSupport@shire.com
To be as brave as the people we help.
13
Contact Information
Shire Pharmaceuticals-SP
Shire HGT
E-mail: ShireSupport@shire.com
E-mail: ShireHGTsupport@shire.com
Phone: 484-595-8253
Phone: 617-613-4999
Funding Site: www.ShireSupport.com
Funding Site: www.ShireHGTsupport.com
Mail: Shire Pharmaceuticals-SP
725 Chesterbrook Blvd
Wayne, PA 19087
Mail: Shire HGT
300 Shire Way
Lexington, MA 02421
Therapeutic Areas of Interest
Adolescent and Adult Attention Deficit
Hyperactivity Disorder
Gastroenterology – Mild to Moderate Ulcerative
Colitis
Gastroenterology – Motility/Chronic Constipation
Hyperphosphatemia (Renal)
Pediatric Attention Deficit Hyperactivity Disorder
Therapeutic Areas
Fabry Diseas
Gaucher Disease
Hereditary Angioedema (HAE)
Hunter Syndrome
Metachromatic Leukodystrophy (MLD)
Sanfilippo Syndrome
To be as brave as the people we help.
14